Xiaoding Xu

16PUBLICATIONS
27CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Dec 02, 2025
Co-Delivery of Chemotherapy and Anti-Angiogenic Lipid via DPPA-LNPs Potentiates Anti-PD-1 Immunotherapy.

Jiabao Tan, Junyue Fang, Wanrong Luo

|May 21, 2025
Dual-Responsive Immunomodulatory RNAi Nanoplatform for Effective Immune Checkpoint Blockade and Enhanced Cancer Immunotherapy.

Yuan Cao, Zixuan Zhao, Junyue Fang

|Jul 05, 2024
Antibody-Decorated Nanoplatform to Reprogram Macrophage and Block Immune Checkpoint LSECtin for Effective Cancer Immunotherapy.

Rui Xu, Xiangya Liu, Yuxuan Zhang

|Nov 03, 2023
Remodeling of Mitochondrial Metabolism by a Mitochondria-Targeted RNAi Nanoplatform for Effective Cancer Therapy.

Rui Xu, Linzhuo Huang, Jiayu Liu

|Aug 12, 2023
Redox-Responsive Polymeric Nanoparticle for Nucleic Acid Delivery and Cancer Therapy: Progress, Opportunities, and Challenges.

Lei Xu, Yuan Cao, Ya Xu

|Jun 16, 2023
Nucleus-specific RNAi nanoplatform for targeted regulation of nuclear lncRNA function and effective cancer therapy.

Zixian Huang, Shaomin Liu, Nan Lu

Pageof 3

Frequent Collaborators

2 joint publications

Wei Tao

2 joint publications

Omid C Farokhzad

2 joint publications

Phei Er Saw

1 joint publications

Wei Jiang